These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 20077137

  • 1. Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.
    Chatsisvili A, Sapounidis I, Pavlidou G, Zoumpouridou E, Karakousis VA, Spanakis M, Teperikidis L, Niopas I.
    Pharm World Sci; 2010 Apr; 32(2):187-93. PubMed ID: 20077137
    [Abstract] [Full Text] [Related]

  • 2. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM, Mikkola JA, Laine K, Airaksinen M.
    Res Social Adm Pharm; 2016 Apr; 12(4):559-68. PubMed ID: 26459026
    [Abstract] [Full Text] [Related]

  • 3. Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran.
    Dirin MM, Mousavi S, Afshari AR, Tabrizian K, Ashrafi MH.
    J Res Pharm Pract; 2014 Jul; 3(3):104-7. PubMed ID: 25328901
    [Abstract] [Full Text] [Related]

  • 4. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study.
    Abbas A, Al-Shaibi S, Sankaralingam S, Awaisu A, Kattezhathu VS, Wongwiwatthananukit S, Owusu YB.
    Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
    [Abstract] [Full Text] [Related]

  • 5. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A, Ludányi Z, Erdős Á, Botz L.
    BMC Pharmacol Toxicol; 2019 May 31; 20(1):36. PubMed ID: 31151485
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV, Guaraldo L, Japiassú AM, Bozza FA.
    J Clin Pharm Ther; 2015 Feb 31; 40(1):63-7. PubMed ID: 25329640
    [Abstract] [Full Text] [Related]

  • 7. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A, Griese N, Schulz M.
    Ann Pharmacother; 2007 Nov 31; 41(11):1825-32. PubMed ID: 17925500
    [Abstract] [Full Text] [Related]

  • 8. Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies.
    Heikkilä T, Lekander T, Raunio H.
    Eur J Clin Pharmacol; 2006 Aug 31; 62(8):661-5. PubMed ID: 16791585
    [Abstract] [Full Text] [Related]

  • 9. The prevalence of major potential drug-drug interactions at a University health centre pharmacy in Jamaica.
    Kennedy-Dixon TG, Gossell-Williams M, Hall J, Anglin-Brown B.
    Pharm Pract (Granada); 2015 Aug 31; 13(4):601. PubMed ID: 26759615
    [Abstract] [Full Text] [Related]

  • 10. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
    Halkin H, Katzir I, Kurman I, Jan J, Malkin BB.
    Clin Pharmacol Ther; 2001 Apr 31; 69(4):260-5. PubMed ID: 11309555
    [Abstract] [Full Text] [Related]

  • 11. Workload and availability of technology in metropolitan community pharmacies.
    Skrepnek GH, Armstrong EP, Malone DC, Abarca J, Murphy JE, Grizzle AJ, Rehfeld RA, Woosley RL.
    J Am Pharm Assoc (2003); 2006 Apr 31; 46(2):154-60. PubMed ID: 16602225
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda.
    Lule AP, Delic OB, Katunguka K, Muwonge F, Yadesa TM.
    BMC Pharmacol Toxicol; 2024 Jan 02; 25(1):2. PubMed ID: 38167526
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M, Gancheva T, Troeva J, Kiriyak N, Hristakieva E.
    Adv Clin Exp Med; 2013 Jan 02; 22(4):555-63. PubMed ID: 23986216
    [Abstract] [Full Text] [Related]

  • 14. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, Rehfeld RA, Woosley RL.
    Med Care; 2007 May 02; 45(5):456-62. PubMed ID: 17446832
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF, Akinwumi AA, Ademola OA, Oluwole BA, Ibiene EO.
    Niger Postgrad Med J; 2017 May 02; 24(2):88-92. PubMed ID: 28762362
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of CYP3A4-related potential drug-drug interactions in outpatients receiving prescriptions from multiple clinical departments.
    Matsuoka R, Akagi S, Konishi T, Kondo M, Matsubara H, Yamamoto S, Izushi K, Tasaka Y.
    J Pharm Health Care Sci; 2024 Aug 05; 10(1):48. PubMed ID: 39103904
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies.
    Abarca J, Colon LR, Wang VS, Malone DC, Murphy JE, Armstrong EP.
    J Manag Care Pharm; 2006 Jun 05; 12(5):383-9. PubMed ID: 16792445
    [Abstract] [Full Text] [Related]

  • 18. Drug related problems identified by community pharmacists on hospital discharge prescriptions in New Zealand.
    Braund R, Coulter CV, Bodington AJ, Giles LM, Greig AM, Heaslip LJ, Marshall BJ.
    Int J Clin Pharm; 2014 Jun 05; 36(3):498-502. PubMed ID: 24700340
    [Abstract] [Full Text] [Related]

  • 19. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies.
    Buurma H, de Smet PA, van den Hoff OP, Egberts AC.
    Br J Clin Pharmacol; 2001 Jul 05; 52(1):85-91. PubMed ID: 11453894
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.